CDMO PLATFORM – SERVICES

Process Development 

Streamline your path from lab to market 

Our process development services are designed to help you achieve scalable, efficient biopharmaceutical production processes that meet the highest quality standards. Whether you need to develop a new process or optimize an existing one, our experts deliver rapid, reliable results tailored to your specific needs. 

Capabilities

Flexible process development
We use Ambr® 250 and small-scale bioreactors (2L to 50L) to develop and optimize processes, with demonstration runs to confirm process performance before scaling up.
Tailored solutions
Our team excels at optimizing processes and at controlling critical product features (e.g. glycosylation pattern), adapting to the unique demands of your product.
Fast characterization
We offer an agile process characterization approach, allowing a smooth and efficient transition from development to commercial production, accelerating your time to market.

Why Choose Us? 

Monoclonal antibody expertise

Our “mAbFast” platform delivers antibody Drug Substance in 12 months reducing time to clinic, making us the ideal partner to transform a lab concept into a biopharmaceutical for human use. 

Comprehensive process support

With expertise in both upstream (cell cultivation) and downstream (product purification) processes, we utilize high-throughput technologies increasing speed and efficiency. 

Custom solutions

Whether you need a process developed de novo or the optimization of an existing process, our flexible approach ensures that we can tailor our services to meet your specific performance and scalability requirements. 

 

Want to learn all about our CDMO platform? Download the brochure